Drug recall · February 19, 2020
Raloxifene Hydrochloride Tablets recall
Why: Failed Dissolution Specifications: Low out of specification results obtained during stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Raloxifene Hydrochloride Tablets, USP, 60 mg, 30 Tablets (3 x 10 blister cards), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-266-21; NDC Unit Dose: 60687-266-11
- Lots / codes
Lot #:180276A, Exp date 02/29/2020
- Quantity
- 973 cartons
- Company
- American Health Packaging, Columbus, OH
- Distribution
- Nationwide within the United States
- Initiated
- December 4, 2019 · Voluntary: Firm initiated
- Classified
- February 21, 2020
- Reported
- February 19, 2020
- Ended
- August 4, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Raloxifene
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.